Atrial fibrillation, the most frequent arrhythmia in clinical practice and chronic coronary
syndrome, is one of the forms of coronary ischemia to have a strong dual relationship. Atrial …

Introduction Balancing antithrombotic therapy for atrial fibrillation (AF) patients undergoing
percutaneous coronary intervention (PCI) remains a clinical challenge due to coexisting …

Background: Atrial Fibrillation (AF) is common in the elderly. A key component of AF
management is Oral Anticoagulant Therapy (OAT), consisting of Vitamin K Antagonists …

Background Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of
stroke and other cardiovascular complications. Oral anticoagulants (OACs) are effective in …

A protocol has been developed for the synthesis of six‐and seven‐membered ring lactams
fused to coumarins through a hydroaminocarbonylation reaction catalyzed by palladium …

Background Triple antithrombotic therapy (TAT), a combination of an oral anticoagulant and
dual antiplatelet therapy (DAPT), is a key treatment for prevention of ischemic events in …

Background Few data are available regarding the prevalence of left atrium (LA) thrombi in
atrial fibrillation (AF) patients treated with non-vitamin K antagonist oral anticoagulants …

Bivalirudin, as a direct thrombin inhibitor, is considered to be safer compared with other
anticoagulants, such as heparin; however, relevant data in China are unclear. The present …

Background: Both Salvianolate Injection and warfarin are widely prescribed in patients with
cardiovascular diseases, but the interaction between them is unknown and needs to be …

Περίληψη Από επιδημιολογικές μελέτες έχει φανεί ότι κολπική μαρμαρυγή και στεφανιαία
νόσος συνυπάρχουν σε μια σημαντική μερίδα του γενικού πληθυσμού. Η βέλτιστη …